Boston Therapeutics/ US63008H1023 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
2019-02-14
Boston Therapeutics Announces Official Sales and Marketing Launch of Sugardown® in Asia
GlobeNewswire
2018-10-03
Boston Therapeutics and Prevail InfoWorks Announce Strategic Clinical Partnership
GlobeNewswire
2018-09-24
Boston Therapeutics Initiates New Exploratory and Adaptive Multicenter Clinical Study of BTI320 On T...
GlobeNewswire
2018-08-09
Boston Therapeutics to launch social commerce channel for Sugardown® in China
GlobeNewswire
2018-06-27
Boston Therapeutics Introduces Sugardown® to the US under kathy Ireland® Health & Wellness
GlobeNewswire
2018-04-16
Boston Therapeutics to Hold Business Update Conference Call Wednesday, April 18, 2018 at 5:00 p.m. E...
GlobeNewswire
2018-04-12
Boston Therapeutics Announces Letter of Intent to Acquire Pennsylvania-based Medical Technology Asso...
GlobeNewswire
2018-03-29
Boston Therapeutics Engages Medical and FDA Experts: Launching New Strategic Initiatives
GlobeNewswire
2018-01-16
Boston Therapeutics, Inc. Introductory Social Media Launch (www.bostonti.com)
GlobeNewswire
2017-12-14
Boston Therapeutics, Inc. Expands Partnership with APC to Distribute in Korea